You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
As the only open-irrigated RF catheter with industrial diamonds to optimize power based on tissue surface temperature, the DiamondTemp™ ablation system (DTA) with RealTemp™ is safe and effective, and has demonstrated procedural efficiencies compared to contact force-sensing RF.1
Indications, Safety, and Warnings
Product DetailsThe Arctic™ Front Advance and Arctic Front Advance Pro™ Cardiac Cryoablation Catheters are approved in the United States to treat drug refractory, recurrent, symptomatic, paroxysmal and persistent atrial fibrillation (episode duration less than 6 months). The Arctic Front Advance and Arctic Front Advance Pro Cardiac Cryoablation Catheters are also approved to treat recurrent, symptomatic, paroxysmal atrial fibrillation as an alternative to anti-arrhythmic drug therapy as an initial rhythm control strategy.
The catheters have a proven safety and efficacy profile in treating AF.2
Indications, Safety, and Warnings
Product DetailsThe Achieve™ and Achieve Advance™ Mapping Catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front family of cardiac cryoablation catheters, the FlexCath™ Advance Steerable Sheath, and the CryoConsole™.
Indications, Safety, and Warnings
Product DetailsThe Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.
Indications, Safety, and Warnings
Product DetailsThe CryoConsole houses the components and software needed to perform cryoablation procedures with the Arctic Front family of cardiac cryoablation catheters or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.
Indications, Safety, and Warnings
Product DetailsThe FlexCath Advance Steerable Sheath is part of the Arctic Front Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front family of cardiac cryoablation catheters. It can also be used with the Freezor MAX Cardiac Cryoablation Catheter.
Indications, Safety, and Warnings
Product DetailsKautzner J, Albenque JP, Natale A, et al. A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation. JACC Clin Electrophysiol. Published online January 20, 2021.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. April 23, 2013;61(16):1713-1723.